AHA Statement on Biden Administration Plan to Battle COVID-19

Rick Pollack
President and CEO
American Hospital Association

December 21, 2021

The AHA welcomes President Biden and his Administration joining us in sounding the alarm over the national workforce crisis facing America’s hospitals and health systems, along with the need to respond to the impact of the current surge and the urgent need to get everyone fully vaccinated and boosted. After nearly two years of battling the COVID-19 pandemic and going absolutely full throttle, our nation’s health care professionals have been pushed to the brink but continue to step up each and every day.

Today’s actions will help hospitals and their caregivers continue to provide the care their patients and communities depend on. We continue to urge the Administration to use all available tools at their disposal and not leave any resources or support on the sidelines. We also reiterate our call for all eligible Americans to get vaccinated and boosted as soon as they can in order to protect themselves, their families and their communities against the worst effects of the virus.



Related Resources

Case Studies
Riley Children’s Health is working to ensure that children, including those under age 5, get the COVID-19 vaccine, by hosting vaccine clinics across the…
Case Studies
While masks have been removed from most school supply lists this season, health care officials say new variants, such as BA.5, can spread quickly putting kids…
At the outset of the COVID-19 pandemic, communities across America entered mandatory quarantines and temporarily shut down many every day services such as…
Case Studies
To encourage Arkansas residents of all ages to get the COVID-19 vaccine and booster, Baptist Health has set up vaccine clinics across the state at banks,…
Advancing Health Podcast
As we start to emerge from the COVID-19 pandemic, understanding and reconnecting to purpose, rediscovering our why is key to moving forward.
What is Paxlovid? Paxlovid (ritonavir-boosted nirmatrelvir) is a preferred oral antiviral authorized for the treatment of mild-moderate COVID-19 illness.…